Erbitux (cetuximab)

pCPA File Number: 20772
Negotiation Status:
Negotiations were not pursued
Indication(s):
Metastatic Colorectal Cancer
Sponsor/Manufacturer:
Eli Lilly Canada Inc.
CDA-AMC Project Number:
PC0031-000
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded: